NCT03257956View on ClinicalTrials.gov

Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 2, 2017

Primary Completion Date

September 20, 2017

Study Completion Date

September 20, 2017

Conditions
Vital Sign Monitoring
Interventions
DEVICE

Investigational Group

The RHEA device and Philips Patient Monitor MX400 are used to monitor the heart rate (HR) and respiratory rate (RR) of participants.

DEVICE

reference group

The reference device Earlysense 2.0 system(vital sign monitoring system) and Philips Patient Monitor MX400 are used to monitor the heart rate (HR) and respiratory rate (RR) of participants.

Trial Locations (1)

02111

Tufts Medical Center, Boston

All Listed Sponsors
collaborator

Tufts Medical Center

OTHER

lead

Darma Inc.

INDUSTRY

NCT03257956 - Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients | Biotech Hunter | Biotech Hunter